search button
Open Access

Systematic re‑analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer

  • Authors:
    • Jun Yu
    • Qianwen Zheng
    • Xiaoxing Ding
    • Bo Zheng
    • Xia Chen
    • Binghai Chen
    • Cong Shen
    • Yu Zhang
    • Xiaojin Luan
    • Yidan Yan
    • Wanyin Chen
    • Bing Xie
    • Min Wang
    • Jiajia Liu
    • Jie Fang
    • Xing Hu
    • Hong Li
    • Chen Qiao
    • Peifang Yang

  • View Affiliations

  • Published online on: June 26, 2019     https://doi.org/10.3892/ol.2019.10527
  • Pages: 2356-2365

  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to identify predictive factors for cervical cancer (CC) progression using a multistage approach. The present study obtained data from 390 healthy women and 259 patients with cervical cancer between June 2012 and June 2017, and used a multiple stage re‑analysis strategy for clinical detection of CC. A total of seven types of serum indices were used in the present study, including sugar chain antigen 125 (CA‑125), sugar chain antigen 199 (CA‑199), α fetoprotein (AFP), carcino‑​embryonic antigen, alkaline phosphatase (ALP), cholesterol and triglyceride (TG). The expression levels of CA‑125, CA‑199, AFP, ALP, cholesterol and TG were significantly different between healthy women and patients with cervical squamous cell carcinoma (SCC). Furthermore, ALP, cholesterol and TG expression levels were significantly different in healthy women compared with patients with cervical adenocarcinoma (AC). Further comparisons based on age and pathological staging demonstrated that the variability in the ALP level was not significant between the <40 years old age group and the 40‑50 years old age group within healthy individuals (P>0.05); however, was significant in patients with SCC (P<0.05). Staging analysis identified significant differences in ALP between healthy women and patients with SCC (Stage I‑IV), and significant differences between healthy women and patients with Stage I AC. The results of the present study indicated that the expression of ALP was significantly increased in patients with CC compared with healthy women. Therefore, ALP may be a potential predictive factor for the development of CC.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yu J, Zheng Q, Ding X, Zheng B, Chen X, Chen B, Shen C, Zhang Y, Luan X, Yan Y, Yan Y, et al: Systematic re‑analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer. Oncol Lett 18: 2356-2365, 2019.
APA
Yu, J., Zheng, Q., Ding, X., Zheng, B., Chen, X., Chen, B. ... Yang, P. (2019). Systematic re‑analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer. Oncology Letters, 18, 2356-2365. https://doi.org/10.3892/ol.2019.10527
MLA
Yu, J., Zheng, Q., Ding, X., Zheng, B., Chen, X., Chen, B., Shen, C., Zhang, Y., Luan, X., Yan, Y., Chen, W., Xie, B., Wang, M., Liu, J., Fang, J., Hu, X., Li, H., Qiao, C., Yang, P."Systematic re‑analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer". Oncology Letters 18.3 (2019): 2356-2365.
Chicago
Yu, J., Zheng, Q., Ding, X., Zheng, B., Chen, X., Chen, B., Shen, C., Zhang, Y., Luan, X., Yan, Y., Chen, W., Xie, B., Wang, M., Liu, J., Fang, J., Hu, X., Li, H., Qiao, C., Yang, P."Systematic re‑analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer". Oncology Letters 18, no. 3 (2019): 2356-2365. https://doi.org/10.3892/ol.2019.10527